Cargando…

Soluble IL-2 alpha and ovarian cancer.

Detalles Bibliográficos
Autor principal:	Barton, D. P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968877/ https://www.ncbi.nlm.nih.gov/pubmed/8123502

Ejemplares similares

Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs
por: Watanabe, Masato, et al.
Publicado: (2022)

Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33
por: Pfeffer, Paul E., et al.
Publicado: (2015)

Alpha 2 mu, alpha 2u, or alpha 2u.
por: Witschi, H
Publicado: (1997)

Co‐operative roles of IL‐4Rα and IL‐13Rα1 in the progression of ovarian carcinomas and the survival of ovarian carcinoma patients
por: Choi, Won Ku, et al.
Publicado: (2023)

Development of a Quantitative Bead Capture Assay for Soluble IL-7 Receptor Alpha in Human Plasma
por: Faucher, Sylvie, et al.
Publicado: (2009)

Effects of IL-11/IL-11 Receptor Alpha on Proliferation and Steroidogenesis in Ovarian Granulosa Cells of Dairy Cows
por: Wu, Hanxiao, et al.
Publicado: (2023)

Biological significance of soluble IL-2 receptor
por: Caruso, Calogero, et al.
Publicado: (1993)

Circulating soluble LIGHT/TNFSF14 is increased and associated with IL-8 concentration in chronic spontaneous urticaria
por: Kasperska-Zając, Alicja, et al.
Publicado: (2018)

Functional Folate Receptor Alpha Is Elevated in the Blood of Ovarian Cancer Patients
por: Basal, Eati, et al.
Publicado: (2009)

The alpha2u-globulin discussion.
por: Ashby, J
Publicado: (1998)

Tumour-derived interleukin 1alpha (IL-1alpha) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells.
por: Fonsatti, E., et al.
Publicado: (1997)

Doubting nongenotoxic mechanisms of renal cancer: comparing apples and oranges in the alpha2u-globulin hypothesis.
por: Dietrich, D R
Publicado: (1997)

Circulating soluble Fas levels and risk of ovarian cancer
por: Akhmedkhanov, Arslan, et al.
Publicado: (2003)

Stromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer
por: Santos, T.D., et al.
Publicado: (2019)

Alpha 2 mu-globulin nephropathy in white ravens.
por: Ashby, J
Publicado: (1996)

Alpha-2 adrenoceptor agonists and sepsis: improved survival?
por: Quintin, Luc
Publicado: (2010)

Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
por: Leow, Melvin Khee Shing
Publicado: (2020)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
por: Sallinen, Hanna, et al.
Publicado: (2014)

Anti-inflammatory cytokines (IL-4, IL-10, IL-13) in plasma during mesenteric infarction.
por: Nathan, N, et al.
Publicado: (1998)

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.
por: Manolitsas, T. P., et al.
Publicado: (1997)

Soluble IL-2 Receptor: A Biomarker for Assessing Myositis Activity
por: Tournadre, Anne, et al.
Publicado: (2014)

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.
por: Mavridou, D., et al.
Publicado: (1998)

Circulating IL-6, IL-10, and TNF-alpha and IL-10/IL-6 and IL-10/TNF-alpha ratio profiles of polyparasitized individuals in rural and urban areas of gabon
por: M’Bondoukwé, Noé Patrick, et al.
Publicado: (2022)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
por: Rădulescu, Carmen, et al.
Publicado: (2016)

Registration of ovarian cancer in England and Wales
por: Quinn, M J, et al.
Publicado: (2000)

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro
por: Hansen, Pernille M., et al.
Publicado: (2022)

Prolonged continuous infusion of low-dose rIL-2.
por: Janssen, R. A., et al.
Publicado: (1994)

AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson’s disease diagnosis
por: Zhao, Hongli, et al.
Publicado: (2017)

RAD51C germline mutations in breast and ovarian cancer patients
por: Akbari, Mohammad R, et al.
Publicado: (2010)

Serum concentrations of soluble (s)L- and (s)P-selectins in women with ovarian cancer
por: Majchrzak-Baczmańska, Dominika B., et al.
Publicado: (2018)

Septic shock, noradrenaline requirements and alpha-2 agonists: Fishing in the right pond?
por: Dargent, Auguste, et al.
Publicado: (2021)

Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
por: Punt, C. J., et al.
Publicado: (1990)

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
por: Guo, Ting, et al.
Publicado: (2021)

Expression of IL-18, IL-18 Binding Protein, and IL-18 Receptor by Normal and Cancerous Human Ovarian Tissues: Possible Implication of IL-18 in the Pathogenesis of Ovarian Carcinoma
por: Medina, Liat, et al.
Publicado: (2014)

A Role for Soluble IL-6 Receptor in Osteoarthritis
por: Akeson, Graham, et al.
Publicado: (2017)

Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?
por: Tuinman, Pieter R, et al.
Publicado: (2011)

The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both?
por: Zhang, Ru-Yuan, et al.
Publicado: (2013)

Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
por: Viviani, S., et al.
Publicado: (1998)

Diagnosis of primary ovarian cancer
por: Wiwanitkit, Viroj
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rvue7r9psvemjd5hugpquuhoma